Loading…
Back To Schedule
Friday, November 1 • 2:00pm - 3:00pm
Medicine - There’s no free lunch in the new age of cancer therapy

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Cancer is the second most frequent cause of death in both the U.S. and Germany, only surpassed by cardiovascular diseases, with a life-time risk of around 40 %. Being one of the clinically most pressing issues in the Western world, billions of dollars are invested each year into developing novel treatment strategies involving digital and personalized medicine. By treating every single patient with a unique strategy much more efficient therapy is possible. However, treatments which are not targeting a broad range of patients anymore are usually associated with a much higher cost to the patient.

What is the potential of these cutting-edge technologies and what is the best way to implement them into our healthcare systems? And how can we achieve an efficient interplay of government, academia and industry on a national and an international level?

The road towards breakthroughs in research is long and the road to making it accessible for patients is even longer. Healthcare, and in particular cancer care, is a topic in which business, economic and public interests crash and which needs coordinated efforts to get from bench to bedside.

Speakers
avatar for ERWIN BÖTTINGER

ERWIN BÖTTINGER

Head of Digital Health Center Hasso Plattner Institute
Erwin Böttinger is head of the Digital Health Center at the Hasso Plattner Institute (HPI) in Potsdam, Germany, and director of the newly formed Hasso Plattner Institute for Digital Health at Mount Sinai Health System in New York City, USA. He holds dual academic appointments as... Read More →
avatar for STEFFAN HO

STEFFAN HO

Head & Vice President Translational Oncology Pfizer Global Product Development
Steffan Ho is Vice President and Head of Translational Oncology at Pfizer in the Global Product Development organization. In this role, he oversees translational and precision medicine strategies that support clinical development across a diverse oncology portfolio.While at Pfizer... Read More →
avatar for ANULA JAYASURIYA

ANULA JAYASURIYA

Founder & Managing Director of EXXclaim Capital
Anula Jayasuriya is a private equity executive and venture capitalist. She founded EXXclaim Capital, an early stage venture fund focused on catalyzing innovation, entrepreneurship and investment in Women’s Health. Anula co-founded the “Evolvence India Life Science Fund”, the... Read More →
avatar for ANITA KATHARINA WAGNER

ANITA KATHARINA WAGNER

Associate Professor Harvard Medical School
Anita Katharina Wagner is an Associate Professor in the Division of Health Policy and Insurance Research at the Department of Population Medicine of Harvard Medical School and the Harvard Pilgrim Health Care Institute. She also serves as the Director of the Harvard Pilgrim Health Care Ethics Program.Dr. Wagner conducts empirical research generating evidence for answering challenging... Read More →
avatar for ROBERT WEINBERG

ROBERT WEINBERG

Founding Member Whitehead Institute for Biomedical Research
Dr. Robert A. Weinberg is a founding member of the Whitehead Institute for Biomedical Research and the Daniel K. Ludwig Professor for Cancer Research at the Massachusetts Institute of Technology (MIT). Dr. Weinberg and his colleagues isolated the first human cancer-causing gene, the... Read More →


Friday November 1, 2019 2:00pm - 3:00pm PDT
The Charles Hotel: Kennedy Room 1 Bennett St, Cambridge, MA 02138, USA